Of the 300 patients in the PARCER trial, 93 faced grades ≥2 adverse events (3D-CRT = 59, IG-IMRT = 34). Patients in the 3D-CRT and IG-IMRT arms spent an average of 2.39 years and 1.96 years in ...
Nucletron BV announced the first clinical treatments combining the advanced inverse planning features of the PLATO treatment planning system with a Siemens linear accelerator. The Radiotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results